Reading the annual reports…

First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.

ALBEMARLE CORP (ALB) financial health, profit and balance sheet · Scorvest

ALB · NYSE · United States · Plastic Materials, Synth Resins & Nonvulcan Elastomers

ALBEMARLE CORP

Charlotte, NC · Fiscal year ends in December · Figures in USD

+ Add to watchlist Compare

In shortALBEMARLE CORP is loss-making, generates cash and carries moderate debt, with revenue shrinking (−4.4% last year).

Financial health

Weak

Built from five areas over the last five annual reports. Tap an area to see the figures behind it.

How is this score calculated? →

Profitability0

Operating marginShare of each sale left after running the business, before interest and tax.	-7.1%	0/100
Net marginShare of each sale left as profit after every cost, interest and tax.	-9.9%	0/100
Return on equityProfit earned on the money shareholders put in. Above 15% is strong.	-5.2%	0/100
Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge.	-2.3%	0/100

Weight in the score: 25%

Balance sheet49

Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash.	2.23×	100/100
Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted.	0.33×	93/100
Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable.	5.40×	0/100
Interest coverageHow many times operating profit covers interest. Below 2 is risky.	-1.77×	0/100
Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress.	3.12	52/100

Weight in the score: 25%

Cash generation50

Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt.	13.5%	74/100
Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy.	–	n/a
Years with positive free cash flow (last 5)	2 of 5	25/100

Weight in the score: 20%

Stability23
Profitable years (last 5) 3 of 5 60/100
Years of revenue decline (last 5) 2 of 5 33/100
Revenue growth volatility 61.2% 0/100
Operating margin volatility 26.4% 0/100
Weight in the score: 20%
Growth0
Revenue growth, 3-year average -11.1% 0/100
EPS growth, 3-year average – n/a
Weight in the score: 10%

Profitable years (last 5)	3 of 5	60/100
Years of revenue decline (last 5)	2 of 5	33/100
Revenue growth volatility	61.2%	0/100
Operating margin volatility	26.4%	0/100

Revenue growth, 3-year average	-11.1%	0/100
EPS growth, 3-year average	–	n/a

Fiscal year 2025 · change vs prior year

Revenue: $5.1B; ▼ 4.4%
Net income: −$510.6M; ▲ 56.7%
Free cash flow: $692.5M; ▲ 169.8%
Operating margin: −7.1%; +25.9 pts
Cash & investments: $1.6B; –
Total debt: $3.2B; ▼ 9.2%
Diluted EPS: −$5.76; ▲ 48.6%
Return on equity: −5.2%; –

Trends

Annual figures as reported. Hover a bar or point for the exact value.

5 older years available with the 10-year history. Essential plan, from €8.25/month →

Revenue and net income

RevenueNet income

Margins

Statements

The last 5 fiscal years from the company's annual reports.

USD millions; negative values in parentheses.

Fiscal year	FY21	FY22	FY23	FY24	FY25
Revenue	3,328	7,320	9,617	5,378	5,143
Cost of revenue	2,330	4,246	8,431	5,315	4,474
Gross profit	998	3,075	1,186	63	669
Research & development	54	72	86	87	51
Selling, general & admin	441	524	910	618	550
Operating income	798	2,470	252	(1,777)	(367)
Interest expense	61	123	116	166	208
Pre-tax income	134	2,433	247	(1,764)	(552)
Income tax	29	391	430	87	157
Net income	124	2,690	1,573	(1,179)	(511)
Diluted EPS	$1.06	$22.84	$13.36	−$11.20	−$5.76
Diluted shares (millions)	117	118	118	118	118

5 older years available with the 10-year history. Essential plan, from €8.25/month →

Risk checks

Altman Z'' score

3.12 Safe zone

Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.

Piotroski F-score

6/9

Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.

Positive net income: failed
Positive operating cash flow: passed
Return on assets improved: passed
Cash flow exceeds net income: passed
Long-term debt ratio fell: failed
Current ratio improved: passed
No share dilution: passed
Gross margin improved: passed
Asset turnover improved: failed

Sources

10-QPeriod ending Jun 30, 2026Filed Aug 5, 2026Open the report ↗
10-QPeriod ending Mar 31, 2026Filed May 6, 2026Open the report ↗
10-K/APeriod ending Dec 31, 2025Filed Mar 31, 2026Open the report ↗
10-KPeriod ending Dec 31, 2025Filed Feb 11, 2026Open the report ↗
10-QPeriod ending Sep 30, 2025Filed Nov 5, 2025Open the report ↗
10-QPeriod ending Jun 30, 2025Filed Aug 4, 2025Open the report ↗
10-QPeriod ending Mar 31, 2025Filed Apr 30, 2025Open the report ↗
10-K/APeriod ending Dec 31, 2024Filed Mar 31, 2025Open the report ↗